Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic

European Journal of Neuroscience

Volumn 13, Issue 5, 2001, Pages 909-915

  Ovalle, S ^a   Zamanillo, D ^a   Andreu, F ^a   Farre A J ^a   Guitart, X ^a  

^a Laboratorios Dr Esteve SA   (Spain)

Author keywords

Gene regulation; Negative symptoms; Neuroleptic; Polymerase chain reaction; Prefrontal cortex; Schizophrenia

Indexed keywords

4 (4 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 [4 (1,2,4 TRIAZOL 1 YL)BUTYL]PYRIDINE; CLOZAPINE; FIBROBLAST GROWTH FACTOR 2; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CHRONOPHARMACOLOGY; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; HYPOTHALAMUS; MALE; NEUROPROTECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; RECEPTOR UPREGULATION; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; MALE; NEURONS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; RNA, MESSENGER; SCHIZOPHRENIA; TRIAZOLES;

EID: 0035102118     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816X.2001.01459.x     Document Type: Article

References (39)

1. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidences
2. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs
3. Fibroblast growth factors: Activities and significance of non-neurotrophin neurotrophic growth factors
4. The FGF family of growth factors and oncogenes
5. Biological roles of fibroblast growth factor-2
6. Single step method of RNA isolation by guanidine thiocyanate-chloroform extraction
7. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs
8. Multiple forms of bFGF, differential nuclear and cell surface localization
9. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by β-adrenergic receptor activation and adrenal steroids in rat central nervous system
10. Functional and anatomical aspects of prefrontal pathology in schizophrenia
11. Spatial learning and physical activity contribute to the induction of fibroblast growth factor: Neural substrates for increased cognition associated with exercise
12. Involvement of σ receptors in the modulation of glutamatergic/NMDA neurotransmission in the dopaminergic systems
13. E-5842
14. E-5842: A new potent and preferential sigma ligand. Preclinical pharmacological profile
15. The effect of E-5842, a σ receptor ligand and potential atypical antipsychotic, on Fos expression in rat forebrain
16. 1 receptor ligand and potential atypical antipsychotic
17. Regulation of gene expression in response to chronic treatment with E-5842, a sigma-1 receptor ligand and potential atypical antipsychotic
18. Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task
19. Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum
20. An open trial of clozapine for dystonia
21. Transforming growth factor-beta mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons
22. Protein measurement with the folin phenol reagent
23. Preclinical pharmacology of atypical antipsychotic drugs: A selective review
24. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast family, which has a unique secretion property
25. Intracellular σ1 receptor modulates phospholipase C and protein kinase C activities in the brainstem
26. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice
27. Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine
28. Schizophrenia: The cellular biology of a functional psychosis
29. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine
30. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity
31. 1 receptor ligand and potential atypical antipsychotic, on A9and A10 dopamine neurons
32. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia
33. Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA
34. σ Receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures
35. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients
36. Brain activation during cognitive stimulation with the Wisconsin Card Sorting Test - A functional MRI study on healthy volunteers and schizophrenics
37. Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia
38. 1 receptor mRNA in rat brain by a putative atypical antipsychotic and sigma receptor ligand